| Dr Thomas J Serey, MD | |
|
2000 E Greenville St, Suite 5140, Anderson, SC 29621-1580 | |
| (864) 716-6100 | |
| (864) 716-6120 |
| Full Name | Dr Thomas J Serey |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 32 Years |
| Location | 2000 E Greenville St, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851398929 | NPI | - | NPPES |
| P01472100 | Other | SC | RR MEDICARE |
| 364939 | Medicaid | SC | |
| 64329303 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 32930 (Kentucky) | Secondary |
| 208800000X | Urology | 36493 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anmed Health | Anderson, SC | Hospital |
| Cannon Memorial Hospital | Pickens, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anmed Health | 1951215243 | 276 |
News Archive
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
Geneva, Switzerland: Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumour is kept to the minimum.
Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710918321 PECOS PAC ID: 1951215243 Enrollment ID: O20031119000738 |
News Archive
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
Geneva, Switzerland: Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumour is kept to the minimum.
Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
Geneva, Switzerland: Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumour is kept to the minimum.
Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas J Serey, MD 2000 E Greenville St, Suite 5140, Anderson, SC 29621-1580 Ph: (864) 716-6100 | Dr Thomas J Serey, MD 2000 E Greenville St, Suite 5140, Anderson, SC 29621-1580 Ph: (864) 716-6100 |
News Archive
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
Geneva, Switzerland: Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumour is kept to the minimum.
Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.
› Verified 9 days ago
Dr. Jeffrey A Larson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Anderson, SC 29621 Phone: 864-716-6100 Fax: 864-716-6120 | |
Dr. Raymond Kirk Seiler, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 2900, Anderson, SC 29621 Phone: 864-716-6100 Fax: 864-716-6120 | |
Dr. Dennis S. Whatley, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 2900, Anderson, SC 29621 Phone: 864-716-6100 Fax: 864-716-6120 | |
Dr. Vidal M Despradel, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 5140, Anderson, SC 29621 Phone: 864-716-6100 Fax: 864-716-6120 | |
Charles William Hinnant Jr., MD JD Urology Medicare: Accepting Medicare Assignments Practice Location: 112 Essex Dr, Anderson, SC 29621 Phone: 864-226-6131 Fax: 864-226-2320 |